4.7 Article

A murine model of Cryptococcus gattii meningoencephalitis

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 67, Issue 6, Pages 1432-1438

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dks060

Keywords

cryptococcal meningoencephalitis; C; gattii; Cryptococcus neoformans; posaconazole; fluconazole

Funding

  1. National Institutes of Health/National Institute of Allergy and Infectious Diseases [N01-AI-25475]
  2. Pfizer
  3. Schering-Plough
  4. Merck
  5. Basilea
  6. Astellas

Ask authors/readers for more resources

Meningoencephalitis caused by Cryptococcus gattii is associated with significant morbidity and the need for aggressive therapy, and often necessitates neurosurgical intervention. We adapted a previously described murine model of cryptococcal meningoencephalitis due to Cryptococcus neoformans to that caused by C. gattii. Mice were inoculated intracranially with either C. gattii (genotype VGIIa) or C. neoformans. In virulence studies, different C. gattii infecting inocula were compared with a fixed inoculum of C. neoformans, and differences were assessed by survival, brain tissue fungal burden, serum antigen titres and histopathological changes within brain tissue. For treatment, fluconazole or posaconazole (10 mg/kg orally twice daily) was initiated 24 h post-inoculation. C. gattii was more virulent than C. neoformans, as evident by shorter median survival, earlier histopathological changes and higher serum antigen titres. However, no differences in fungal burden or dissemination to other organs were observed among the various groups. In treatment studies, both fluconazole and posaconazole improved the median survival of mice infected with either species. However, neither regimen improved the percentage of animals surviving to the predetermined study endpoint. These results demonstrate the virulence of C. gattii meningoencephalitis and the potential of this model for the assessment of new treatment strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study

Prithviraj Bose, David McCue, Sebastian Wurster, Nathan P. Wiederhold, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Lucia Masarova, Koichi Takahashi, Zeev Estrov, Musa Yilmaz, Naval Daver, Naveen Pemmaraju, Kiran Naqvi, Caitlin R. Rausch, Kayleigh R. Marx, Wei Qiao, Xuelin Huang, Carol A. Bivins, Sherry A. Pierce, Hagop M. Kantarjian, Dimitrios P. Kontoyiannis

Summary: In patients with newly diagnosed AML/MDS undergoing remission-induction chemotherapy, ISAV is a safe and effective alternative for antifungal prophylaxis, with excellent tolerability and minimal adverse effects such as mild to moderate elevation of liver function tests.

CLINICAL INFECTIOUS DISEASES (2021)

Article Dermatology

In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes

Hamid Badali, Connie Canete-Gibas, Hoja Patterson, Carmita Sanders, Barbara Mermella, Victor Garcia, James Mele, Hongxin Fan, Nathan P. Wiederhold

Summary: Olorofim showed good in vitro activity against clinical isolates of the Fusarium oxysporum and F solani species complexes, similar to amphotericin B, while other drugs exhibited inconsistent in vitro activity. Further studies are needed to determine its in vivo efficacy.

MYCOSES (2021)

Article Microbiology

Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis

Teclegiorgis Gebremariam, Sondus Alkhazraji, Abdullah Alqarihi, Nathan P. Wiederhold, Laura K. Najvar, Thomas E. Patterson, Scott G. Filler, Ashraf S. Ibrahim

Summary: Biomedical research shows some differences between male and female mice infected with invasive pulmonary mucormycosis, but these differences have no impact on the outcome of treatment or host immune response.

JOURNAL OF FUNGI (2021)

Article Microbiology

Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States

Hamid Badali, Connie Canete-Gibas, Dora McCarthy, Hoja Patterson, Carmita Sanders, Marjorie P. David, James Mele, Hongxin Fan, Nathan P. Wiederhold

Summary: This study evaluated the epidemiology and susceptibility profiles of Mucorales isolates in the United States, finding Rhizopus as the predominant genus, the respiratory tract as the main source of isolates, and amphotericin B and posaconazole as the most active antifungal drugs, with isavuconazole showing the greatest variability.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Fisheries

Retrospective study of phaeohyphomycosis in aquarium-housed fish, with first descriptions of Exophiala lecanii-corni and Neodevriesia cladophorae in fish

Abigail R. Armwood, Connie F. Canete-Gibas, Jennifer A. Dill-Okubo, Nathan P. Wiederhold, Alvin C. Camus

Summary: A study on phaeohyphomycosis cases in a diverse range of aquarium-housed fish species found that the disease mostly affects bony fish, particularly marine species. The most common fungal genus identified was Exophiala, with two new species described for the first time in fish. Pathologically, lesions were most frequently observed in the skin/fin, skeletal muscle, and kidneys.

JOURNAL OF FISH DISEASES (2021)

Article Veterinary Sciences

Disseminated Rasamsonia argillacea species complex infections in 8 dogs

Jonathan D. Dear, Krystle L. Reagan, Sean E. Hulsebosch, Chai-Fei Li, Matthew John Lodge Munro, Barbara A. Byrne, Verena K. Affolter, Nathan Wiederhold, Connie Canete-Gibas, Jane E. Sykes

Summary: This study describes the clinical features, radiographic findings, pathological characteristics, and outcomes of dogs with disseminated Rasamsonia species complex infections. The infection involves multiple systems such as the vertebral column, central nervous system, kidneys, spleen, lymph nodes, lungs, and heart. Molecular techniques are necessary for proper identification and treatment guidance.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2021)

Review Infectious Diseases

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

Sharon C-A Chen, John Perfect, Arnaldo L. Colombo, Oliver A. Cornely, Andreas H. Groll, Danila Seidel, Kerstin Albus, Joao Nobrega de Almedia, Guillermo Garcia-Effron, Nicole Gilroy, Cornelia Lass-Floerl, Luis Ostrosky-Zeichner, Livio Pagano, Tamas Papp, Riina Rautemaa-Richardson, Jon Salmanton-Garcia, Andrej Spec, Joerg Steinmann, Sevtap Arikan-Akdagli, Dorothee E. Arenz, Rosanne Sprute, Luisa Duran-Graeff, Tomas Freiberger, Corrado Girmenia, Michelle Harris, Souha S. Kanj, Maryam Roudbary, Olivier Lortholary, Joseph Meletiadis, Esther Segal, Felipe Francisco Tuon, Nathan Wiederhold, Tihana Bicanic, Jagdish Chander, Yee-Chun Chen, Po-Ren Hsueh, Margaret Ip, Patricia Munoz, Isabel Spriet, Elvis Temfack, Luis Thompson, Anna Maria Tortorano, Aristea Velegraki, Nelesh P. Govender

Summary: This article discusses the increasing prevalence of rare yeast infections in immunocompromised or seriously ill patients, highlighting the importance of comprehensive multidisciplinary management. It also addresses the need for region-specific or updated management guidelines, while noting that expert opinions and in-vitro susceptibility results play a key role in treatment recommendations for these infections.

LANCET INFECTIOUS DISEASES (2021)

Article Mycology

Pseudocanariomyces americanus, gen. nov., sp. nov., A New Thielavia-Like Species in the Chaetomiaceae: Identification and Management of a Prosthetic Hip Infection

Keenan Ryan, Connie Canete-Gibas, Carmita Sanders, Nestor Sosa, Nathan P. Wiederhold

Summary: This report presents the phenotypic characteristics of a novel fungal species isolated from a prosthetic hip infection, identified as a new thielavia-like species through DNA sequencing and phylogenetic analysis. The patient responded well to antifungal treatment and remained stable without complications.

MYCOPATHOLOGIA (2021)

Article Medicine, Research & Experimental

First report of human infection caused by Colletotrichum chlorophyti occurring in a post-corneal transplant patient with endophthalmitis

Alberto E. Paniz-Mondolfi, Steven Agemy, Connie Canete-Gibas, Melissa R. Gitman, Codrin E. Iacob, Inna Necula, Ching-Yi Wang, Lourdes A. Delgado Noguera, Carmita Sanders, Nathan P. Wiederhold, Emilia M. Sordillo, Michael D. Nowak

Summary: Keratomycosis, caused by various fungi including Colletotrichum species, is a major cause of ophthalmic morbidity worldwide. The first reported case of C. chlorophyti infection in a post-corneal transplant patient indicates an increasing role for Colletotrichum species as emerging human pathogens, especially in transplant populations.

MEDICAL MYCOLOGY CASE REPORTS (2021)

Article Pharmacology & Pharmacy

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Martin Hoenigl, Rosanne Sprute, Matthias Egger, Amir Arastehfar, Oliver A. Cornely, Robert Krause, Cornelia Lass-Florl, Juergen Prattes, Andrej Spec, George R. Thompson, Nathan Wiederhold, Jeffrey D. Jenks

Summary: The epidemiology of invasive fungal infections is changing due to increased usage of antifungal agents leading to resistance. Limited therapeutic options are further challenged by drug-drug interactions, toxicity, and administration constraints. Despite the lack of new antifungal drug classes in the past two decades, there are promising new classes in late-stage clinical development, offering hope for improved treatment options.

DRUGS (2021)

Article Microbiology

Diagnosis from Tissue: Histology and Identification

Raquel Sabino, Nathan Wiederhold

Summary: The accurate identification of fungal pathogens is essential for the diagnosis and treatment of invasive fungal infections. Histopathology provides provisional identification but must be combined with laboratory results for improved accuracy.

JOURNAL OF FUNGI (2022)

Article Microbiology

Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo

Laura S. Burrack, Robert T. Todd, Natthapon Soisangwan, Nathan P. Wiederhold, Anna Selmecki

Summary: Antifungal drug resistance and tolerance are a serious threat to global public health. This study investigated the evolution of drug resistance in Candida auris and found rapid acquisition of resistance mutations and the stability of resistance in the absence of drugs. The genetic background of clinical isolates was also found to affect the evolutionary potential and acquisition of resistance. These findings highlight the high stability and high rates of acquisition of antifungal resistance in C. auris, which can lead to the evolution of pan-resistant isolates in clinical settings.
Review Microbiology

Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents

Nathan P. Wiederhold

Summary: Several new antifungals with novel pharmacodynamics/mechanisms of action are being developed, as well as modified agents within established classes. These drugs have the potential to combat fungal strains with reduced susceptibility or acquired resistance to current antifungals, and may improve clinical outcomes for patients with invasive fungal infections.

JOURNAL OF FUNGI (2022)

Article Immunology

Rigidoporus corticola Colonization and Invasive Fungal Disease in Immunocompromised Patients, United States

Alvaro C. Laga, Jessica W. Crothers, Connie F. Canete-Gibas, Nathan P. Wiederhold, Isaac H. Solomon

Summary: Two cases of Rigidoporus corticola infection in humans in the United States are reported, illustrating previously undescribed clinicopathologic manifestations of this filamentous basidiomycete in humans.

EMERGING INFECTIOUS DISEASES (2022)

Article Mycology

A revision of malbranchea-like fungi from clinical specimens in the United States of America reveals unexpected novelty

Ernesto Rodriguez-Andrade, Jose F. Cano-Lira, Nathan Wiederhold, Alba Perez-Cantero, Josep Guarro, Alberto M. Stchigel

Summary: The study investigated clinical fungi of the order Onygenales from a reference laboratory in the USA, identifying new genera and species. Echinocandins demonstrated the highest in vitro antifungal activity against the fungi, followed by terbinafine and posaconazole.

IMA FUNGUS (2021)

No Data Available